Eric Venker
Presidente en ROIVANT SCIENCES LTD. .
Fortuna: 5 M $ al 30/04/2024
Cargos activos de Eric Venker
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
IMMUNOVANT, INC. | Director/Miembro de la Junta | 18/02/2020 | - |
ROIVANT SCIENCES LTD. | Director de Operaciones | 01/11/2018 | - |
Presidente | 01/01/2021 | - | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Director de Operaciones | 01/11/2018 | - |
Presidente | 01/01/2021 | - | |
Corporate Officer/Principal | 01/01/2017 | 01/11/2018 | |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Director/Miembro de la Junta | - | - |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Director/Miembro de la Junta | - | - |
Director de Operaciones | - | - | |
Roivant Social Ventures, Inc. | Director/Miembro de la Junta | 01/01/2014 | - |
Historial de carrera de Eric Venker
Antiguos cargos conocidos de Eric Venker.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SIO GENE THERAPIES INC. | Director/Miembro de la Junta | 17/02/2020 | 05/04/2023 |
ARBUTUS BIOPHARMA CORPORATION | Director/Miembro de la Junta | 01/02/2020 | 25/05/2022 |
Independent Dir/Board Member | 01/02/2020 | 25/05/2022 | |
ROIVANT SCIENCES LTD. | Director de Operaciones | - | - |
Presidente | - | - | |
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formación de Eric Venker.
Yale School of Medicine | Doctorate Degree |
St. Louis College of Pharmacy | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 11 |
Suiza | 2 |
Reino Unido | 2 |
Operativa
Director/Board Member | 6 |
Chief Operating Officer | 4 |
President | 3 |
Sectorial
Health Technology | 8 |
Consumer Services | 4 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
IMMUNOVANT, INC. | Health Technology |
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
ROIVANT SCIENCES LTD. | Health Technology |
Empresas privadas | 6 |
---|---|
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Health Technology |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Montes Archimedes Acquisition Corp.
Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA. | Finance |
Roivant Social Ventures, Inc. |
- Bolsa de valores
- Insiders
- Eric Venker
- Experiencia